Esophageal Adenocarcinoma
About
Mappings
NCI Thesaurus: Esophageal Adenocarcinoma (coding:ncit:C4025)
OncoTree: Esophageal Adenocarcinoma (coding:oncotree:ESCA)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | PD-L1 (CPS) >= 10 | Esophageal Adenocarcinoma | Pembrolizumab | |
| EMA (1) | PD-L1 (CPS) >= 10 | Esophageal Adenocarcinoma | Cisplatin, Fluorouracil, Pembrolizumab | |
| EMA (1) | HER2-negative, PD-L1 (CPS) >= 5 | Esophageal Adenocarcinoma | Fluorouracil, Nivolumab, Oxaliplatin | |
| EMA (1) | HER2-negative, PD-L1 (CPS) >= 5 | Esophageal Adenocarcinoma | Capecitabine, Nivolumab, Oxaliplatin |